Products: The 30 gene pan-cancer panel

BRCATESTUK Products: The pan-cancer panel

Analysing up to 30 genes to help women and men understand their risk for the most common hereditary cancers

Comprehensive analysis of up to 30 genes 

The pan-cancer panel analyses the 30 genes associated with the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate*, stomach, and uterine. These genes were carefully selected based on scientific studies showing strong association with risk of the most common types of hereditary cancer. 

The genes are as follows: APC, CDH1, MLH1, POLE, ATM, CDK4, MSH2, PTEN, BAP1, CDKN2A (p14ARF), MSH6, RAD51C, BARD1, CDKN2A (p16INK4a), MUTYH, RAD51D, BMPR1A, CHEK2, NBN, SMAD4, BRCA1, EPCAM, PALB2, STK11, BRCA2, GREM1, PMS2, TP53, BRIP1, MITF, POLD1

Informative results 

Clear, thorough communication of the presence of any risk-increasing mutations, including mutation details and the impact on cancer risks

Detailed information on how your mutation status might affect relatives 

Screening guidelines created by experts to discuss with your healthcare provider, answers to common questions 

Meet the team
The professionals behind our hereditary cancer testing service
What's it all about?
Fighting back against cancer – and protecting your family
About the test
How the hereditary cancer testing service works
Medical professionals
How our service can help you and your patients
How to purchase through your insurance provider
These organisations are experts in their fields
Get in touch
Contact us for a free telephone consultation

BRCATESTUK uses the Color test within our service

Color Genomics test is part of BRCATESTUK's hereditary cancer testing service